(Q27664223)
Statements
Discovery of 4-(5-(cyclopropylcarbamoyl)-2-methylphenylamino)-5-methyl-N-propylpyrrolo[1,2-f][1,2,4]triazine-6-carboxamide (BMS-582949), a clinical p38α MAP kinase inhibitor for the treatment of inflammatory diseases (English)
0 references
23 September 2010
0 references
53
0 references
18
0 references
6629-39
0 references